Tesla: Robotaxi Begins Testing With Non-Tesla Employees, With Limitations

Based on April and May data showing a sales decline, we think Tesla is likely to see a second straight quarter of lower deliveries.

Ladegerät mit Tesla-Logo an einer Supercharger-Schnellladestation für das Elektrofahrzeugunternehmen Tesla Motors.
Smith Collection/Gado via Getty

Key Morningstar Metrics for Tesla

On June 22, select Tesla TSLA customers began testing the company’s robotaxi service. Tesla shares were up slightly in premarket trading on June 23.

Why it matters: Non-Tesla employees testing the ride-hailing service is another step toward the robotaxi entering commercial service. The test also featured a ride-hailing app. This supports our view that the firm will successfully enter the robotaxi ride-hailing market.

  • The test highlighted the improvement needed before Tesla can launch a full robotaxi service. For example, employees sat in passenger seats as safety monitors. Additionally, the service currently will not test from midnight to 6 a.m., or in the rain.
  • The testing area was also limited to a geofenced part of Austin, Texas, roughly half the size of Waymo’s operating area. Given that geofencing is not a part of its long-term plan, we view this as a sign that Tesla is still in an earlier testing phase.

The bottom line: We maintain our $250 fair value estimate for narrow-moat Tesla. We view the shares as overvalued, currently trading a little more than 30% above our fair value estimate and in 2-star territory.

Coming up: Tesla is set to report second-quarter deliveries in early July. Based on April and May data showing a sales decline, we think Tesla is likely to see a second straight quarter of lower deliveries.

  • We expect Tesla will continue to test robotaxis from now until its earnings call in mid- to late July. We hope to hear an update from management on the key steps for Tesla’s path to full robotaxi commercialization.

Editor's Note: This analysis was originally published as a stock note by Morningstar Equity Research.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.